Incontinence, intermittent self-catheterization and the artificial genitourinary sphincter.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 6737574)

Published in J Urol on August 01, 1984

Authors

D M Barrett, W L Furlow

Articles citing this

Artificial urinary sphincters. Br Med J (Clin Res Ed) (1985) 0.75

Articles by these authors

Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol (1994) 2.10

Percutaneous removal of kidney stones: review of 1,000 cases. J Urol (1985) 2.04

Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol (1994) 1.75

Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of 323 cases. J Urol (1998) 1.66

High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol (2000) 1.44

Long-term followup and evaluation of primary realignment of posterior urethral disruptions. J Urol (1997) 1.40

Visual laser ablation of the prostate: a preliminary report. Mayo Clin Proc (1995) 1.40

Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter. J Urol (1980) 1.29

High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology (1998) 1.28

Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol (1995) 1.28

Management of high grade transitional cell cancer of the upper urinary tract. J Urol (1981) 1.20

Comparison of techniques for vesicourethral anastomosis: simple direct versus modified Vest traction sutures. Urology (1988) 1.13

Acute panautonomic neuropathy. Ann Neurol (1983) 1.11

Surgical management of impotence using the inflatable penile prosthesis: experience with 103 patients. Br J Urol (1978) 1.11

High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology (1997) 1.06

Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology (1996) 1.04

Natural history of prostatism: urinary flow rates in a community-based study. J Urol (1993) 1.04

A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence. J Urol (1996) 1.03

Vaginal metastasis from renal cell carcinoma: radiographic evidence of possible route of spread. J Urol (1970) 1.02

Colorimetric method for the determination of lipoxygenase activity. J Agric Food Chem (2001) 1.02

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology (1996) 1.01

Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group. J Urol (1999) 1.01

Artificial urinary sphincter cuff erosion. Experience with reimplantation in 38 patients. Urology (1990) 1.00

Surgical management of impotence using the inflatable penile prosthesis. Experience with 36 patients. Mayo Clin Proc (1976) 0.97

Giant leiomyoma of the prostate. Arch Pathol Lab Med (1987) 0.96

Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study Group. Neurourol Urodyn (1999) 0.95

Success of de novo reimplantation of the artificial genitourinary sphincter. J Urol (2000) 0.94

Nephropexy: fact or fiction? Urology (1976) 0.94

Inflatable penile prosthesis: Mayo Clinic experience with 175 patients. Urology (1979) 0.94

Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res (2002) 0.93

Percutaneous removal of kidney stones. Preliminary report. Mayo Clin Proc (1982) 0.92

The artificial urinary sphincter in the female: indications for use, surgical approach and results. Int Urogynecol J Pelvic Floor Dysfunct (1998) 0.92

Flow evaluation and simultaneous external sphincter electromyography in clinical urodynamics. J Urol (1981) 0.91

Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer (1992) 0.91

Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol (1987) 0.91

Stented versus nonstented ureteroileal anastomoses: is there a difference with regard to leak and stricture? J Urol (1985) 0.91

Observations on vesical diverticulum in childhood. J Urol (1976) 0.90

Artificial urethral sphincter for incontinence. Urology (2000) 0.90

Recurrent or persistent urinary incontinence in patients with the artificial urinary sphincter: diagnostic considerations and management. J Urol (1985) 0.89

The model AS 800 artificial urinary sphincter: Mayo Clinic experience. J Urol (1987) 0.89

The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol (1981) 0.87

An implantable mechanical urinary sphincter: a new nonhydraulic design concept. Urology (1998) 0.86

Mayo Clinic experience with use of the AMS800 artificial urinary sphincter for urinary incontinence following radical prostatectomy. J Urol (1989) 0.86

Use of the artificial urinary sphincter in the management of severe incontinence in females. Surg Gynecol Obstet (1985) 0.86

Primary realignment of posterior urethral injuries. J Urol (1983) 0.85

The management of severe urinary incontinence in patients with myelodysplasia by implantation of the AS 791/792 urinary sphincter device. J Urol (1982) 0.85

Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy. Urology (1993) 0.85

Postprostatectomy urinary incontinence: a comparison of the cost of conservative versus surgical management. Urology (1998) 0.85

Low-density lipoprotein antioxidant activity of phenolic compounds and polyphenol oxidase activity in selected clingstone peach cultivars. J Agric Food Chem (2000) 0.85

Corporeal reconstruction and prosthetic implantation for impotence associated with non-dilatable corporeal cavernosal fibrosis. Acta Urol Belg (1992) 0.84

Use of the artificial urinary sphincter in men and women. World J Urol (1997) 0.84

Symptomatic ureteral stumps. J Urol (1971) 0.84

Salvage of the eroded inflatable penile prosthesis: a new concept. J Urol (1987) 0.84

Postprostatectomy urinary incontinence: etiology, prevention, and selection of surgical treatment. Urol Clin North Am (1978) 0.84

The Jonas prosthesis--technical considerations and results. J Urol (1983) 0.83

Success of the narrow-backed cuff design of the AMS800 artificial urinary sphincter: analysis of 144 patients. J Urol (1993) 0.83

Peyronie's disease: a study of its natural history and treatment with orthovoltage radiotherapy. J Urol (1975) 0.83

Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. J Urol (1999) 0.83

Pericatheter retrograde urethrography: introduction of a new device and technique. J Urol (1989) 0.82

The implantable artificial genitourinary sphincter in the management of total urinary incontinence. Mayo Clin Proc (1976) 0.82

Candida albicans cystitis: report of a case with special emphasis on diagnosis and treatment. J Urol (1973) 0.82

Evaluation of psychogenic urinary retention. J Urol (1978) 0.82

Pharmacotherapeutic advances in the treatment of erectile dysfunction. Mayo Clin Proc (1999) 0.82

Combined implantation of artificial sphincter and penile prosthesis. J Urol (1989) 0.81

Radical prostatectomy incontinence and the AS791 artificial urinary sphincter. J Urol (1983) 0.80

Prosthetic bladder augmentation and replacement. Semin Urol (1984) 0.80

Patient and partner satisfaction with the AMS 700 penile prosthesis. J Urol (1992) 0.80

Carcinoma of the penis: a clinicopathologic study. J Urol (1970) 0.79

Transurethral enzymatic ablation of the prostate: canine model. Urology (1996) 0.79

Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of urethral atrophy? Urology (2001) 0.79

High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clin Proc (1998) 0.79

Management of nondilatable cavernous fibrosis with the use of a downsized inflatable penile prosthesis. J Urol (1995) 0.79

Inflatable penile prosthesis: follow-up study of patient-partner satisfaction. Urology (1979) 0.79

Primary lymphoma of prostate: transrectal ultrasonic appearance. Urology (1990) 0.79

Anastomotic obstruction after stapled enteroanastomosis. Surgery (1991) 0.79

Rectal injury occurring at radical retropubic prostatectomy for prostate cancer: etiology and treatment. Urology (1993) 0.78

Transpubic urethroplasty. J Urol (1976) 0.78

A new temporary catheter (ContiCath) for the treatment of temporary, reversible, postoperative urinary retention. Urology (1999) 0.78

Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Urology (1996) 0.78

Urothelial substitutes: bladder. J Endourol (1993) 0.78

Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia. Cancer (1991) 0.78

Realities of diagnosing Helicobacter pylori infection in clinical practice: a case for non-invasive indirect methodologies. Yale J Biol Med (1999) 0.78

Clinical research priorities in renal cell carcinoma: renal cell carcinoma chemoprevention strategies including target populations, proposed agents, and clinical trial designs--Workgroup No. 6. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 0.78

Transitional cell carcinoma of the kidney with vena caval involvement: report of 3 cases and a review of the literature. J Urol (1992) 0.77

Bilateral localized amyloidosis of the ureter presenting with anuria. J Urol (1978) 0.77

The effect of parity of the dam on sexual maturation, serum concentrations of metabolic hormones and the response to luteinizing hormone releasing hormone in bull calves. Reprod Domest Anim (2010) 0.77

Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer. J Urol (1983) 0.77

Treatment of penile fibrosis with prosthetic implantation and flap advancement with tissue debulking. J Urol (1996) 0.77

Microscopic quantification of cell integrity in raw and processed onion parenchyma cells. J Food Sci (2010) 0.77

Psychogenic urinary retention in women. Mayo Clin Proc (1976) 0.77

Renal cell carcinoma in multicystic dysplastic kidney. Urology (1980) 0.77

The Euplotes crassus conjugation-specific conN1 gene encodes a transcription elongation factor TFIIS-like protein. J Eukaryot Microbiol (2002) 0.76

Influence of cell integrity on textural properties of raw, high pressure, and thermally processed onions. J Food Sci (2010) 0.76

Neurogenic vesical dysfunction in diabetes mellitus: another look at vesical neck resection. J Urol (1974) 0.76

Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Finasteride Urodynamics Study Group. Urology (1999) 0.76